Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Biogen Inc (BIIB)

Biogen Inc (BIIB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
115.17 +1.79 (+1.58%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 114.91 -0.26 (-0.23%) 18:38 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
112.18
Day High
116.39
Open 114.32
Previous Close 113.38 113.38
Volume 1,618,900 1,618,900
Avg Vol 1,895,815 1,895,815
Stochastic %K 18.50% 18.50%
Weighted Alpha -48.47 -48.47
5-Day Change -7.81 (-6.35%) -7.81 (-6.35%)
52-Week Range 110.04 - 238.00 110.04 - 238.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,858,008
  • Shares Outstanding, K 146,375
  • Annual Sales, $ 9,676 M
  • Annual Income, $ 1,632 M
  • EBIT $ 2,696 M
  • EBITDA $ 3,660 M
  • 60-Month Beta 0.06
  • Price/Sales 1.72
  • Price/Cash Flow 4.91
  • Price/Book 0.99

Options Overview Details

View History
  • Implied Volatility 55.52% ( +2.36%)
  • Historical Volatility 41.03%
  • IV Percentile 98%
  • IV Rank 78.52%
  • IV High 64.86% on 04/09/25
  • IV Low 21.36% on 09/10/24
  • Put/Call Vol Ratio 0.36
  • Today's Volume 3,177
  • Volume Avg (30-Day) 2,939
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 93,201
  • Open Int (30-Day) 87,278

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 33 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.52
  • Number of Estimates 25
  • High Estimate 4.23
  • Low Estimate 1.94
  • Prior Year 3.67
  • Growth Rate Est. (year over year) -4.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
110.04 +4.66%
on 04/09/25
Period Open: 143.66
145.97 -21.10%
on 03/18/25
-28.49 (-19.83%)
since 03/11/25
3-Month
110.04 +4.66%
on 04/09/25
Period Open: 148.82
157.09 -26.69%
on 03/10/25
-33.65 (-22.61%)
since 01/10/25
52-Week
110.04 +4.66%
on 04/09/25
Period Open: 203.68
238.00 -51.61%
on 07/12/24
-88.51 (-43.46%)
since 04/11/24

Most Recent Stories

More News
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
MPC : 123.43 (+1.56%)
AAPL : 198.15 (+4.06%)
JNJ : 151.73 (+2.04%)
AMGN : 285.98 (+1.62%)
PFE : 21.91 (+1.48%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
FANG : 129.01 (+4.75%)
AMD : 93.40 (+5.30%)
SPY : 533.94 (+1.78%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
MPC : 123.43 (+1.56%)
AAPL : 198.15 (+4.06%)
ADI : 179.16 (+0.45%)
JNJ : 151.73 (+2.04%)
AMGN : 285.98 (+1.62%)
PFE : 21.91 (+1.48%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
FANG : 129.01 (+4.75%)
AMD : 93.40 (+5.30%)
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

BMRN : 56.82 (+0.89%)
VRTX : 484.22 (+1.84%)
MRNA : 26.20 (+6.94%)
UTHR : 281.16 (+0.81%)
BIIB : 115.17 (+1.58%)
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

BIIB : 115.17 (+1.58%)
Stocks Finish Higher as Magnificent Seven Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. June E-mini S&P...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
UAL : 65.60 (+4.54%)
AAPL : 198.15 (+4.06%)
PVH : 68.88 (-0.39%)
ADI : 179.16 (+0.45%)
JNJ : 151.73 (+2.04%)
MRK : 79.18 (+2.10%)
TXN : 147.60 (-5.75%)
$IUXX : 18,690.05 (+1.89%)
PFE : 21.91 (+1.48%)
ZNM25 : 109-270 (+0.10%)
Analysts Love These 2 Growth Stocks That Have Over 200% Upside Potential

Wall Street expects both of these biotech stocks to soar over 200% in the next 12 months.

AKBA : 1.6500 (+6.45%)
STOK : 7.02 (+7.67%)
ACAD : 14.58 (+3.33%)
BIIB : 115.17 (+1.58%)
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025

Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to the company.

LLY : 732.41 (+1.60%)
BIIB : 115.17 (+1.58%)
3 Value Stocks Walking a Fine Line

3 Value Stocks Walking a Fine Line

MTW : 7.67 (+0.92%)
SGH : 20.85 (+0.43%)
BIIB : 115.17 (+1.58%)
Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

BIIB : 115.17 (+1.58%)
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

SRPT : 51.03 (+1.43%)
BMRN : 56.82 (+0.89%)
ABBV : 175.05 (+0.49%)
MRNA : 26.20 (+6.94%)
BIIB : 115.17 (+1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 121.19
2nd Resistance Point 118.79
1st Resistance Point 116.98
Last Price 115.17
1st Support Level 112.77
2nd Support Level 110.37
3rd Support Level 108.56

See More

52-Week High 238.00
Fibonacci 61.8% 189.12
Fibonacci 50% 174.02
Fibonacci 38.2% 158.92
Last Price 115.17
52-Week Low 110.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar